Skip to content

Muscle Fatigability and Trip-specific Fall Risk in Adults With Knee Osteoarthritis

Muscle Fatigability and Trip-specific Fall Risk in Adults With Knee Osteoarthritis

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06229691
Enrollment
24
Registered
2024-01-29
Start date
2024-05-14
Completion date
2025-08-27
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee

Keywords

balance, fatigue, falls

Brief summary

The goal of this clinical trial is to learn about how fatigue affects the risk of falling in adults aged 55-70 years with and without knee osteoarthritis. The main questions this trial aims to answer are: * Does fatigue increase the risk of tripping while walking? and * Does fatigue increase the risk of falling in response to a trip while walking? Participants will * Complete questionnaires * Wear a device that measures physical activity for 5-7 days * Complete a 30 minute walk on a treadmill * Complete the following before and after the treadmill walk: * Computer test to measure mental fatigue * Maximal strength testing * Balance test Researchers will compare adults with and without knee osteoarthritis to see if fall risk in adults with knee osteoarthritis is affected more by walking activity compared to adults without knee osteoarthritis.

Interventions

BEHAVIORAL30 minute treadmill walk

Participants will walk on a treadmill at their preferred speed for 30 minutes. One minute "challenge" periods will occur at minutes 7, 17, and 27, when the treadmill speed will increase by 50%. This walk will induce a magnitude of muscle fatigue corresponding to an individual participant's fatigability.

Sponsors

University of Delaware
Lead SponsorOTHER
National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

For adults with knee osteoarthritis: * presence of occasional to frequent knee pain * knee pain that is primarily in the medial knee joint compartment * minimal morning joint stiffness For all participants: * able to walk continuously for 30 minutes without an assistive device

Exclusion criteria

* fracture or surgery within 1 year * history of joint replacement * lower-extremity joint injections within 3 months * history of stroke or other neurological condition * cardiovascular or pulmonary conditions that limit daily activity or that preclude participation in exercise * history of major lower extremity or back injury or pain (except for knee osteoarthritis) * history of lower extremity amputation * use an orthotic or prosthetic to walk * use of beta blockers or other medications that affect fatigue * use of medications that affect balance * diabetic neuropathy * acute illness or the presence of lesions on the torso or lower extremities * BMI greater than 35 * body weight over 265 lbs

Design outcomes

Primary

MeasureTime frameDescription
Minimum toe clearance during walkingBeginning and end of 30 minute treadmill walkMinimum toe clearance will be calculated from the first and last minutes of the treadmill walk using optical motion capture.
Anterior stability margins during walkingBeginning and end of 30 minute treadmill walkAnterior stability margins will be calculated from the first and last minutes of the treadmill walk using optical motion capture.
Anterior reactive steppingBeginning and end of 30 minute treadmill walkStability margins will be calculated from a lean-release test conducted before and after the 30 minute treadmill walk
Knee extensor fatigabilityBefore and after the 30 minute treadmill walkKnee extensor fatigability will be calculated as the change in maximum knee extensor power (measured via dynamometry) pre- to post-30 minute treadmill walk

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026